Social Sciences · Sociology and Political Science
Meningococcal Outbreak Ad Hoc Work Group
Jessica Macneil Mph, Doug Campos-outcalt, Kathy Harriman, Lee Harrison, Lorry Rubin, Carol Baker, Susan Even (acha, Meghan Ferris (fda, Scott Kapoor, Lucia Lee (fda, Cody Meissner, Paul Offit
See on the mapAbstract
There is no vaccine for serogroup B meningococcal disease (MenB) licensed in the United States Outbreaks on college campuses highlight the challenge of controlling serogroup B meningococcal disease Vaccinat ion campaigns were conducted at two universit ies experiencing serogroup B outbreaks in 2013 using a MenB vaccine that is not licensed in the United States under an expanded access IND sponsored by CDC 2 Expanded Access Invest igat ional New Drug (IND) The U.S. Food and Drug Administrat ion’s (FDA) current regulat ions allow the use of a drug or vaccine that is not approved in the United States to treat serious or immediately life-threatening diseases or condit ions when there are no comparable or sat isfactory alternat ive treatment opt ions 3